Daunorubicin
IIT-2016-RP-HEM-LD-DNR
Phase 1 small_molecule completed
Quick answer
Daunorubicin for Acute Lymphocytic Leukemia is a Phase 1 program (small_molecule) at Protara Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protara Therapeutics
- Indication
- Acute Lymphocytic Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed